A comprehensive view of non-vaccine biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Pfizer Listed a New Clinical Trial to Understand Long-term Safety and Effects of Fordadistrogene Movaparvovec Experimental Gene Therapy for Duchenne Muscular Dystrophy
Published:
January 20, 2023
by Contify Life Science News
|
Merck wraps up US$1.35B deal for US-based Imago Biosciences; Imago to become wholly-owned subsidiary of Merck
Published:
January 12, 2023
by SeeNews Deals
|
Autobahn Therapeutics announces initiation of a Phase 1 clinical trial of ABX-002 for the treatment for major depressive disorder; ABX-002 is a selective brain-boosting thyroid receptor beta agonist
Published:
December 29, 2022
by Contify Life Science News
|
Pfizer, partnering with Sosei Group, announces dosing of first subject in Phase 2 clinical trial of PF-07081532, a candidate for treatment of type 2 diabetes and obesity; trial marks a development milestone, triggering US$10M payment to Sosei
Published:
December 21, 2022
by Globe Newswire
|
Roche announces FDA approval of Actemra intravenous infusion for treatment of COVID-19 in hospitalized adults; product is first monoclonal antibody approved by the FDA for COVID-19
Published:
December 21, 2022
by GlobeNewswire Europe
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count